Hepatic Encephalopathy — West Haven Grading
Select the grade that best matches the patient's current neurological status.
Podrobný sprievodca čoskoro
Pracujeme na komplexnom vzdelávacom sprievodcovi pre Hepatic Encephalopathy Grading (West Haven). Čoskoro sa vráťte pre podrobné vysvetlenia, vzorce, príklady z praxe a odborné tipy.
Hepatic encephalopathy (HE) is a spectrum of neuropsychiatric abnormalities occurring in patients with significant liver dysfunction, caused by the accumulation of neurotoxic substances — most notably ammonia — that the failing liver cannot adequately clear or metabolise. It is classified as covert (minimal or grade 1) or overt (grades 2–4), and can be episodic, recurrent, or persistent depending on the clinical course. The West Haven Criteria (WHC) are the most widely used grading system for classifying the severity of hepatic encephalopathy: Grade 0 has no clinical evidence of HE but subtle neuropsychiatric changes may be detected with psychometric testing (referred to as minimal HE or covert HE); Grade 1 involves trivial lack of awareness, shortened attention span, altered sleep pattern, and mild personality changes; Grade 2 is characterised by lethargy, disorientation, asterixis (flapping tremor), and obvious personality change; Grade 3 involves somnolence, gross disorientation, bizarre behaviour, and asterixis may be present; Grade 4 is coma with or without response to painful stimuli. Hepatic encephalopathy is a major complication of cirrhosis, occurring in up to 30–45% of patients with cirrhosis over their lifetime, and is associated with significant morbidity, impaired quality of life, and increased mortality. The most common precipitating factors include infections (especially spontaneous bacterial peritonitis), gastrointestinal bleeding, constipation, electrolyte disturbances, medications (sedatives, opioids), and non-adherence to lactulose therapy. Treatment involves identifying and reversing precipitating factors, administering lactulose to reduce ammonia production and absorption, and using rifaximin as secondary prophylaxis to prevent recurrence.
West Haven Grade 0: no clinical HE (covert: minimal changes detectable only on psychometric testing); Grade 1: trivial changes; Grade 2: lethargy/disorientation/asterixis; Grade 3: somnolence/gross confusion; Grade 4: coma
- 1Assess orientation and cognition: ask the patient for their name, current date, location, and year. Disorientation to time (day, month, year) characterises Grade 2; disorientation to place or person escalates towards Grade 3.
- 2Assess level of consciousness: full alertness (Grade 0–1), somnolence but rousable (Grade 2–3), or unarousable (Grade 4 — coma).
- 3Test for asterixis (flapping tremor): ask the patient to extend arms with dorsiflexed wrists for 15–30 seconds. Rhythmic flapping movements indicate Grade 2–3 HE. Note: asterixis cannot be assessed in comatose patients (Grade 4).
- 4Assess personality and behaviour: mild changes such as euphoria, irritability, or minor sleep disturbances suggest Grade 1; overt behavioural change, disinhibition, or aggression suggests Grade 2; bizarre/gross personality disturbance points to Grade 3.
- 5For covert HE (Grade 0–1), standard bedside assessment is insensitive — validated psychometric tools (e.g., the Psychometric Hepatic Encephalopathy Score [PHES], Stroop test, or CFF) are needed to detect minimal HE.
- 6Identify and treat precipitating factors: send blood cultures, urinalysis, ascitic fluid analysis (SBP), check electrolytes, renal function, blood glucose, and review all medications. Constipation, infection, and GI bleeding account for most episodes.
- 7Initiate treatment: lactulose 30–45 mL orally up to 3–4 times daily, titrating to produce 2–3 soft stools per day; for secondary prophylaxis (especially after first overt episode), add rifaximin 550 mg twice daily.
Associated with impaired driving ability and reduced quality of life despite no clinical signs
Covert HE is clinically silent but detectable on validated tests. It affects approximately 30–40% of cirrhotic patients and is associated with a 3-fold increased risk of overt HE development within 1 year.
Initiate lactulose; identify and treat precipitants; hospital admission required
Grade 2 HE constitutes overt hepatic encephalopathy. This patient needs urgent precipitant search (infection screen, check for GI bleeding, electrolyte review) and lactulose titration to 2–3 soft stools per day.
Monitor airway; consider ICU; lactulose via NG tube if oral route unsafe
Grade 3 HE carries significant risk of airway compromise. Lactulose should be administered via nasogastric tube. Urgent review of MELD score, precipitants, and transplant status is mandatory.
Immediate intubation and ICU; urgent transplant evaluation; poor prognosis without transplant
Grade 4 HE (hepatic coma) carries very high mortality without liver transplantation. Immediate airway management and organ support are required. MELD and transplant eligibility must be reassessed urgently.
Professionals in health and medical use Hepatic Encephalopathy as part of their standard analytical workflow to verify calculations, reduce arithmetic errors, and produce consistent results that can be documented, audited, and shared with colleagues, clients, or regulatory bodies for compliance purposes.
University professors and instructors incorporate Hepatic Encephalopathy into course materials, homework assignments, and exam preparation resources, allowing students to check manual calculations, build intuition about input-output relationships, and focus on conceptual understanding rather than arithmetic.
Consultants and advisors use Hepatic Encephalopathy to quickly model different scenarios during client meetings, enabling real-time exploration of what-if questions that would otherwise require returning to the office for detailed spreadsheet-based analysis and reporting.
Individual users rely on Hepatic Encephalopathy for personal planning decisions — comparing options, verifying quotes received from service providers, checking third-party calculations, and building confidence that the numbers behind an important decision have been computed correctly and consistently.
Extreme input values
In practice, this edge case requires careful consideration because standard assumptions may not hold. When encountering this scenario in hepatic encephalopathy calculations, practitioners should verify boundary conditions, check for division-by-zero risks, and consider whether the model's assumptions remain valid under these extreme conditions.
Assumption violations
In practice, this edge case requires careful consideration because standard assumptions may not hold. When encountering this scenario in hepatic encephalopathy calculations, practitioners should verify boundary conditions, check for division-by-zero risks, and consider whether the model's assumptions remain valid under these extreme conditions.
Rounding and precision effects
In practice, this edge case requires careful consideration because standard assumptions may not hold. When encountering this scenario in hepatic encephalopathy calculations, practitioners should verify boundary conditions, check for division-by-zero risks, and consider whether the model's assumptions remain valid under these extreme conditions.
| Grade | Consciousness | Intellect/Behaviour | Neurological Signs | Classification |
|---|---|---|---|---|
| 0 | Normal | Normal | None clinically (psychometric tests may be abnormal) | Covert HE (Minimal HE) |
| 1 | Mild awareness deficit, shortened attention | Trivial personality changes, euphoria or anxiety, sleep disturbance | Mild asterixis or tremor | Covert HE (Grade 1) |
| 2 | Lethargy, slowed responses | Disorientation (time), obvious personality change, inappropriate behaviour | Asterixis present, slurred speech | Overt HE |
| 3 | Somnolent but rousable, confusion | Gross disorientation, bizarre behaviour, amnesia | Asterixis, muscular rigidity | Overt HE |
| 4 | Coma — no response to stimuli | — | Absent or decorticate/decerebrate posturing | Overt HE — Hepatic Coma |
What causes hepatic encephalopathy?
In the context of Hepatic Encephalopathy, this depends on the specific inputs, assumptions, and goals of the user. The underlying formula provides a deterministic relationship between inputs and output, but real-world application requires interpreting the result within the broader context of health and medical practice. Professionals typically cross-reference calculator output with industry benchmarks, historical data, and regulatory requirements. For the most reliable results, ensure inputs are sourced from verified data, understand which assumptions the formula makes, and consider running multiple scenarios to bracket the range of likely outcomes.
What is the difference between covert and overt hepatic encephalopathy?
Hepatic Encephalopathy is a specialized calculation tool designed to help users compute and analyze key metrics in the health and medical domain. It takes specific numeric inputs — typically drawn from real-world data such as measurements, rates, or quantities — and applies a validated mathematical formula to produce actionable results. The tool is valuable because it eliminates manual calculation errors, provides instant feedback when exploring different scenarios, and serves as both a decision-support instrument for professionals and a learning aid for students studying the underlying principles.
How does lactulose work in hepatic encephalopathy?
In the context of Hepatic Encephalopathy, this depends on the specific inputs, assumptions, and goals of the user. The underlying formula provides a deterministic relationship between inputs and output, but real-world application requires interpreting the result within the broader context of health and medical practice. Professionals typically cross-reference calculator output with industry benchmarks, historical data, and regulatory requirements. For the most reliable results, ensure inputs are sourced from verified data, understand which assumptions the formula makes, and consider running multiple scenarios to bracket the range of likely outcomes.
What is rifaximin and why is it used?
Rifaximin is a minimally absorbed antibiotic that acts locally in the gastrointestinal tract to reduce ammonia-producing bacteria. It is used as secondary prophylaxis following a first episode of overt HE to reduce the risk of recurrence. The RFHE trial demonstrated that rifaximin 550 mg twice daily reduced HE recurrence by 58% over 6 months compared to placebo.
What are the most common precipitants of hepatic encephalopathy?
In the context of Hepatic Encephalopathy, this depends on the specific inputs, assumptions, and goals of the user. The underlying formula provides a deterministic relationship between inputs and output, but real-world application requires interpreting the result within the broader context of health and medical practice. Professionals typically cross-reference calculator output with industry benchmarks, historical data, and regulatory requirements. For the most reliable results, ensure inputs are sourced from verified data, understand which assumptions the formula makes, and consider running multiple scenarios to bracket the range of likely outcomes.
Can ammonia levels alone diagnose or grade hepatic encephalopathy?
In the context of Hepatic Encephalopathy, this depends on the specific inputs, assumptions, and goals of the user. The underlying formula provides a deterministic relationship between inputs and output, but real-world application requires interpreting the result within the broader context of health and medical practice. Professionals typically cross-reference calculator output with industry benchmarks, historical data, and regulatory requirements. For the most reliable results, ensure inputs are sourced from verified data, understand which assumptions the formula makes, and consider running multiple scenarios to bracket the range of likely outcomes.
Is hepatic encephalopathy reversible?
Episodic overt HE is usually reversible with treatment of the precipitant and lactulose therapy. However, after multiple episodes of overt HE, some patients develop persistent cognitive impairment (post-HE cognitive impairment or liver-related dementia) that does not fully resolve. Liver transplantation can reverse HE in most patients if performed before irreversible neurological damage occurs.
What is the relationship between MELD score and hepatic encephalopathy?
Overt HE is a criterion for the Child-Pugh score (grade 3–4 scores 3 points). MELD does not directly include HE but correlates with it because high MELD reflects advanced hepatic dysfunction, which predisposes to HE. HE episodes significantly increase 1-year mortality in cirrhotic patients and can trigger urgent MELD reassessment and transplant listing.
Pro Tip
Always perform a thorough precipitant search before attributing altered consciousness to hepatic encephalopathy: check blood glucose (hypoglycaemia), send blood cultures and ascitic fluid analysis, review medications for sedatives and opioids, and consider CT head to exclude subdural haematoma — common in cirrhotic patients due to falls and coagulopathy.
Did you know?
The term 'hepatic coma' was used long before the West Haven criteria were formalised in 1977. Ancient Egyptian physicians described comatose patients with jaundice as having a 'liver gone black', and some historians believe that the death of Alexander the Great in 323 BC — characterised by fever, jaundice, severe abdominal pain, and progressive stupor — may represent acute liver failure with hepatic coma, possibly from typhoid-induced fulminant hepatitis.
References
- ›Vilstrup H et al. Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by EASL and AASLD. J Hepatol 2014.
- ›Bass NM et al. (RFHE Trial) Rifaximin Treatment in Hepatic Encephalopathy. NEJM 2010.
- ›Conn HO et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. Gastroenterology 1977.
- ›EASL Clinical Practice Guidelines on Hepatic Encephalopathy in Chronic Liver Disease 2022
- ›MDCalc — Hepatic Encephalopathy Grading